← All trials
NCT04364555
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2020
- Primary completion
- Apr 30, 2022
- Completion date
- Apr 30, 2022
- First posted
- Apr 28, 2020
- Last posted
- Apr 28, 2020
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Malmö UniversityLead sponsor
- Lund UniversityCollaborator
- Malmö UniversityStudy chair
- Malmö UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.